Combined with the key role of FLI-1 in angiogenesis mentioned above, FLI-1-targeted inhibitors seem to not only inhibit the malignant proliferation of tumour cells but also constitute one of the strategies for inhibiting angiogenesis to reduce tumour metastasis. The gene discussed is FLI1; the disease is neoplasm.